top of page
Latest News
Search


A New Single-Tablet Option for HIV's "Forgotten Population" Could Change Lives. Will Policy Let It?
New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

Travis Roppolo
Mar 309 min read


CROI 2026: The Tools Are Here. The Infrastructure Is Not.
CROI 2026 showcased breakthroughs alongside funding crisis disrupting global and domestic HIV services.

Travis Roppolo
Mar 88 min read
Breakthroughs in HIV Research from CROI 2024
Major HIV research breakthroughs from CROI 2024: long-acting treatments and prevention advances.

Travis Roppolo
Mar 24, 20247 min read
We Need Your Support Today!
bottom of page